Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
- ETH Zurich
- University of Basel
- University of Zurich
- Nature Careers
- Empa
- ETH Zürich
- Paul Scherrer Institut Villigen
- University of Bern
- University of Geneva
- ;
- EPFL
- EPFL FSB
- ETH ZURICH
- Ecole Polytechnique Federale de Lausanne
- European Magnetism Association EMA
- Fluxim AG
- Friedrich Miescher Institute for Biomedical Research
- Graduate Institute of International and Development Studies
- Swiss Federal Institute for Forest, Snow and Landscape Research WSL
- University of California
- 10 more »
- « less
-
Field
-
interfaces for fast, stable energy storage. Our research explores molecular interactions and charge transfer using advanced spectroscopy. This guides the development of better batteries and supercapacitors. We
-
handle working time flexibly so that you can take time to prepare for exams or fulfill other study obligations. Profile Current master's student at ETH or another Swiss University/FH (kein Urlaubssemester
-
for a PhD Student in Fabrication of Quantum Devices Your tasks Development of scalable fabrication methods of quantum nanostructures and devices using EUV lithography and e-beam lithography Close
-
the responsible recruiters and not by artificial intelligence. ETH Zurich is one of the world’s leading universities specialising in science and technology. We are renowned for our excellent education, cutting-edge
-
100%, Zurich, fixed-term At MYNERVA – a Wyss Zurich project – our mission is to improve the lives of individuals suffering from neuropathy. MYNERVA has developed a medical device to artificially
-
is to clean up, organize, and prepare the diverse datasets collected during the Cloudlab seeding experiments. This involves working with data from a suite of in-situ and remote sensing instruments
-
of Riccardo Catena at Chalmers University. The overall goal of the project is to develop, numerically implement, and apply a theoretical framework to accurately describe the expected dark matter-induced
-
to engineer human cells and develop advanced gene and cell therapies targeting cancer, as well as metabolic, neurodegenerative, autoimmune and infectious diseases. For more information, please consult our
-
associate professorship. Candidates from the Global South are particularly encouraged to apply. The successful applicant will be expected to lead the development of research in their field at the Institute
-
human tissues. These gaps hinder the development of physiologically relevant laboratory models for drug discovery. As part of the Swiss research network http://www.nccr-antiresist.ch/ , the Bumann lab